| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.26 | 0.01 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.01 |